Healio Gastroenterology presents the following reports on the most recent research on COVID-19 is gastrointestinal conditions.
These reports include new research on the impact of COVID-19 in GI bleeding, GI neoplasia detection, transmission during endoscopy and its effect on fecal microbiota transmission.
Anticoagulants do not increase GI bleeding in COVID-19
Anticoagulation use or antiplatelet agents were not risk factors for gastrointestinal bleeding in hospitalized COVID-19 patients, according to a study published in Journal of Internal Medicine. READ MORE
COVID-19: 1st wave significantly reduced GI neoplasia detection
A typically high-volume endoscopy unit in Italy saw a significant reduction in procedures in the early stages of the COVID-19 pandemic, according to research presented at ESGE Days.